OKYO Pharma (OKYO) Cash & Current Investments (2021 - 2025)
OKYO Pharma (OKYO) reported Cash & Current Investments of $4.2 million for Q3 2025, up 410.42% year-over-year from $826848.0 in Q3 2024, and up 410.42% quarter-over-quarter from $826848.0 in Q1 2025.
OKYO Pharma (OKYO) Cash & Current Investments (2021 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has 5 years of Cash & Current Investments data on file, last reported at $4.2 million in Q3 2025.
- Cash & Current Investments for Q3 2025 came in at $4.2 million, up 410.42% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.2 million (up 410.42% YoY), and the FY2025 annual result was $826848.0, changed 0.0% from the prior year.
- Cash & Current Investments advanced to $4.2 million in Q3 2025 per OKYO's latest filing, from $826848.0 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $6.9 million in Q1 2021 and troughed at $826848.0 in Q1 2024.
- A 5-year average of $3.0 million and a median of $3.4 million in 2022 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments sank 79.56% in 2024, then surged 410.42% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $6.9 million in 2021, then sank by 60.8% to $2.7 million in 2022, then jumped by 49.79% to $4.0 million in 2023, then slumped by 79.56% to $826848.0 in 2024, then surged by 410.42% to $4.2 million in 2025.
- Business Quant data shows OKYO's Cash & Current Investments at $4.2 million in Q3 2025, $826848.0 in Q1 2025, and $826848.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | OKYO Pharma | 244.98 Mn | 240.76 Mn | - | 4.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 826,848.00 |
| Sep 30, 2024 | 826,848.00 |
| Mar 31, 2024 | 826,848.00 |
| Sep 30, 2023 | 4.05 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Mar 31, 2021 | 6.89 Mn |